Added to YB: 2026-08-27
Pitch date: 2026-08-18
VETO.PA [neutral]
Vetoquinol SA
+1.41%
current return
Author Info
DB_Silver_Fox is a CFO and value investor interested in: European & US hidden champions, simple and effective business models, and US Banks. Sign up for the newsletter.
Company Info
Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
Market Cap
EUR 819.4M
Pitch Price
EUR 70.80
Price Target
N/A
Dividend
1.32%
EV/EBITDA
5.60
P/E
14.28
EV/Sales
1.17
Sector
Pharmaceuticals
Category
value
DB_Silver_Fox | Portfolio update as of 11.08.2026 - Vetoquinol SA
VETO.PA (hold): Family-owned Vetoquinol, managed conservatively for the long term, has conservative/solid capital allocation: over 5 years it generated €400m in cash flow from operations, spending 28% on CAPEX, 28% on debt repayment, and returning ~15% to shareholders via dividends and buybacks; balance sheet is rock solid, growing organically with increasing net cash. Risk: the 'Essentials' strategy sells branded off-patent products others invented, capping pricing at roughly 2% a year (enough to cover input inflation), keeping operating margins between 10-15% for two decades. Author likes the setup especially with the stock down ~50%.
Read full article (1 min)